Quick Dispatch:
Your tirzepatide diabetes trial Tirzepatide Matches Dulaglutide in Large CV Outcomes Trial: SURPASS-CVOT orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your tirzepatide diabetes trial Tirzepatide Matches Dulaglutide in Large CV Outcomes Trial: SURPASS-CVOT ships.
Need Help?
Questions about tirzepatide diabetes trial Tirzepatide Matches Dulaglutide in Large CV Outcomes Trial: SURPASS-CVOT, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for tirzepatide diabetes trial Tirzepatide Matches Dulaglutide in Large CV Outcomes Trial: SURPASS-CVOT in your area.
Lilly Decides to Advance Tirzepatide for Obesity
28.87
Adding tirzepatide to basal insulin cuts HbA1c levels in people with poorly controlled type 2 diabetes
20.21
❇️ Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes 🟠BACKGROUND Tirzepatide, a dual incretin agonist of the glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptors, has favorable effects on
28.52
How the weight loss drug tirzepatide is also helping heart failure patients
23.82
Comparison of Dose Escalation Versus Switching to Tirzepatide Among People With Type 2 Diabetes Inadequately Controlled on Lower Doses of Dulaglutide: A Randomized Clinical Trial: Annals of Internal Medicine: Vol 178, No 5
29.24
At a glance factsheet: Tirzepatide for management of type 2 diabetes
26.95
💡 New insight in diabetes care: In patients with T2DM and ASCVD, the SURPASS-CVOT trial found that tirzepatide was noninferior to dulaglutide for major cardiovascular events (12.2% vs 13.1%; HR 0.92). What
22.02
